DALLAH HEALTHCARE COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162 SAR | 0.00% |
|
-0.74% | -5.70% |
| Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 14 | Dallah Healthcare Logs Higher FY23 Net Profit, Revenue | MT |
Evolution of the average Target Price on Dallah Healthcare Company
Price target over the last 5 years
History of analyst recommendation changes
8bb0c184fcf3bfbe4826a799.lwTGm7nVB6axnlMZOL2hjXObLjBZOTHfsWRk43BfC_o.9GuUq4qlSfbGywpIS_jVtUb4F0UxCH6N5DwgiS89fKzQZ6Os1Yx26obnJA~f8dfd245e3a0b6fc49dbe98ed02fa2b4
Analysts' Consensus
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
162
SAR
Average target price
154.4
SAR
Spread / Average Target
-4.70%
High Price Target
183
SAR
Spread / Highest target
+12.96%
Low Price Target
106
SAR
Spread / Lowest Target
-34.57%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4004 Stock
- Consensus Dallah Healthcare Company
